Decellularized fresh homografts for pulmonary valve replacement: a decade of clinical experience
S Sarikouch, A Horke, I Tudorache… - European Journal of …, 2016 - academic.oup.com
OBJECTIVES Decellularized homografts have shown auspicious early results when used
for pulmonary valve replacement (PVR) in congenital heart disease. The first clinical …
for pulmonary valve replacement (PVR) in congenital heart disease. The first clinical …
Systemic inflammatory response syndrome after pediatric congenital heart surgery: Incidence, risk factors, and clinical outcome
…, M Sasse, A Karch, F Dziuba, A Horke… - Journal of cardiac …, 2017 - Wiley Online Library
BACKGROUND Systemic inflammatory response syndrome (SIRS) is frequent after cardiac
surgery, but data on its incidence and perioperative risk factors are scarce for children with …
surgery, but data on its incidence and perioperative risk factors are scarce for children with …
A European study on decellularized homografts for pulmonary valve replacement: initial results from the prospective ESPOIR Trial and ESPOIR Registry data
D Boethig, A Horke, M Hazekamp… - European journal of …, 2019 - academic.oup.com
… Alexander Horke … Dietmar Boethig and Alexander Horke authors contributed equally to
this study. … Dietmar Boethig and Alexander Horke authors contributed equally to this study. …
this study. … Dietmar Boethig and Alexander Horke authors contributed equally to this study. …
Decellularized aortic homografts for aortic valve and aorta ascendens replacement
I Tudorache, A Horke, S Cebotari… - European Journal of …, 2016 - academic.oup.com
OBJECTIVES The choice of valve prosthesis for aortic valve replacement (AVR) in young
patients is challenging. Decellularized pulmonary homografts (DPHs) have shown excellent …
patients is challenging. Decellularized pulmonary homografts (DPHs) have shown excellent …
Early systemic cellular immune response in children and young adults receiving decellularized fresh allografts for pulmonary valve replacement
…, S Cebotari, D Boethig, A Horke… - … Engineering Part A, 2014 - liebertpub.com
Objectives: The longevity of homografts is determined by the activation of the recipients'
immune system resulting from allogenic antigen exposition. Fresh decellularized pulmonary …
immune system resulting from allogenic antigen exposition. Fresh decellularized pulmonary …
Early results from a prospective, single-arm European trial on decellularized allografts for aortic valve replacement: the ARISE study and ARISE Registry data
A Horke, I Tudorache, G Laufer… - European Journal of …, 2020 - academic.oup.com
OBJECTIVES Decellularized aortic homografts (DAH) may provide an additional aortic
valve replacement option for young patients due to their potential to overcome the high early …
valve replacement option for young patients due to their potential to overcome the high early …
[HTML][HTML] Strategic anti-SARS-CoV-2 serology testing in a low prevalence setting: the COVID-19 Contact (CoCo) Study in healthcare professionals
…, A Zychlinsky Scharff, C Dopfer, A Horke… - Infectious diseases and …, 2020 - Springer
Background Serology testing is explored for epidemiological research and to inform individuals
after suspected infection. During the coronavirus disease 2019 (COVID-19) pandemic, …
after suspected infection. During the coronavirus disease 2019 (COVID-19) pandemic, …
Elastogenesis at the onset of human cardiac valve development
M Votteler, DAC Berrio, A Horke, L Sabatier… - …, 2013 - journals.biologists.com
Semilunar valve leaflets have a well-described trilaminar histoarchitecture, with a sophisticated
elastic fiber network. It was previously proposed that elastin-containing fibers play a …
elastic fiber network. It was previously proposed that elastin-containing fibers play a …
5-Year results from the prospective European multi-centre study on decellularized homografts for pulmonary valve replacement ESPOIR Trial and ESPOIR Registry …
D Bobylev, A Horke, D Boethig… - European Journal of …, 2022 - academic.oup.com
OBJECTIVES Early results from the prospective ESPOIR Trial have indicated excellent
results for pulmonary valve replacement using decellularized pulmonary homografts (DPH). …
results for pulmonary valve replacement using decellularized pulmonary homografts (DPH). …
Long-term results after repair of anomalous origin of left coronary artery from the pulmonary artery: Takeuchi repair versus coronary transfer
…, A Haverich, D Boethig, A Horke - European Journal of …, 2017 - academic.oup.com
OBJECTIVES We evaluated long-term results of two different repair strategies of anomalous
origin of left coronary artery from pulmonary artery (ALCAPA) in two German surgical centres…
origin of left coronary artery from pulmonary artery (ALCAPA) in two German surgical centres…